---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-098792"
form_type: "8-K"
ticker: "LQDA"
cik: "0001819576"
company_name: "Liquidia Corp"
filed_at: "2024-09-11T23:59:59+00:00"
generated_at: "2026-05-31T05:29:01.684275+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Liquidia raises ~$100M from stock offerings and RIFA advance for YUTREPIA development

## Summary
- Public offering of 6,460,674 shares at $8.90/share for ~$57.5M gross; private placement of 1,123,595 shares at $8.90/share for $10M.
- Fifth Amendment to RIFA with HCR provides additional $32.5M, bringing total RIFA to $100M; funding condition met upon stock offering close.
- Modified fixed payment schedule extends RIFA termination from 2029 to 2031; $23.8M payment deferred to 2026.
- Proceeds to fund YUTREPIA commercial development, pediatric/WHO Group 1/3 trials, and L606 clinical development.
- BofA Securities sole bookrunner; fund affiliated with Paul Manning invested ~$3M in offering.

## SEC filing metadata
- accession: 0001104659-24-098792
- form_type: 8-K
- ticker: LQDA
- cik: 0001819576
- company_name: Liquidia Corp
- filed_at: 2024-09-11T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819576/000110465924098792/0001104659-24-098792-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819576/000110465924098792/tm2423751d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-098792
- JSON: https://secwatch.observer/filing/0001104659-24-098792.json
- Plain text: https://secwatch.observer/filing/0001104659-24-098792.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.